CompletedPHASE1, PHASE2NCT01434121

Ascorbic Acid (Vitamin C) Infusion in Human Sepsis

Studying Acute lung injury

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Virginia Commonwealth University
Principal Investigator
Alpha Fowler, MD, M.D
Virginia Commonwealth University
Intervention
Ascorbic Acid(drug)
Enrollment
24 enrolled
Eligibility
18 years · All sexes
Timeline
20102012

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01434121 on ClinicalTrials.gov

Other trials for Acute lung injury

Additional recruiting or active studies for the same condition.

See all trials for Acute lung injury

← Back to all trials